European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes Treated With Immediate Release Quetiapine or Extended Release Quetiapine.
Phase of Trial: Phase IV
Latest Information Update: 01 May 2014
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 24 Oct 2012 Status changed from active, no longer recruiting to completed as reported by UKCRN.
- 24 Jun 2011 Lead trial investigator (Domingo Gonzalez Naranjo) added as reported by ClinicalTrials.gov.
- 16 Apr 2011 Status changed from recruiting to active, no longer recruiting, as reported by the UKCRN record (study is in follow-up)